Filing Details
- Accession Number:
- 0001127602-20-020885
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-02 16:10:54
- Reporting Period:
- 2020-06-30
- Accepted Time:
- 2020-07-02 16:10:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1682852 | Moderna Inc. | MRNA | Biological Products, (No Disgnostic Substances) (2836) | 813467528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1690927 | Zvi Tal Zaks | C/O Moderna, Inc. 200 Technology Square Cambridge MA 02139 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-06-30 | 24,121 | $19.15 | 24,121 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-06-30 | 15,631 | $19.15 | 39,752 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-06-30 | 5,400 | $62.83 | 34,352 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-06-30 | 12,967 | $63.56 | 21,385 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-06-30 | 21,385 | $64.57 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-06-30 | 24,121 | $0.00 | 24,121 | $19.15 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-06-30 | 15,631 | $0.00 | 15,631 | $19.15 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 300,173 | 2026-08-10 | No | 4 | M | Direct | |
| 284,542 | 2026-08-10 | No | 4 | M | Direct |
Footnotes
- The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.11 to $63.11. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.12 to $64.12. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.13 to $65.11. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- This option is fully vested and exercisable.
Billionaire Hedge Funds
